Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Oxandrolone to Promote Growth in Infants With Hypoplastic Left Heart Syndrome: A Phase I/II Pilot Study

NCT04090697 is registered in ClinicalTrials.gov with Carelon Research as lead sponsor.

NCT NCT04090697
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04090697 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Oxandrolone to Promote Growth in Infants With Hypoplastic Left Heart Syndrome: A Phase I/II Pilot Study
Lead sponsor
Carelon Research
Phase
Phase 1/2
Overall status
Terminated
Start date
December 20, 2019
Completion date
September 19, 2023
Enrollment
34 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

congenital heart disease, hypoplastic left heart